These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15103922)

  • 1. [Mass screening for prostate cancer in Tokushima City: the results of 2001].
    Kanayama HO; Kagawa S; Utsunomiya M; Kawashima S; Takehisa I; Sumitani H; Yokozeki H
    Nihon Hinyokika Gakkai Zasshi; 2004 Mar; 95(3):596-603. PubMed ID: 15103922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mass screening for prostate cancer in Ikeda City Osaka].
    Tsutahar K; Yokoyama S; Fukuhara S; Mori N; Hara T; Yamaguchi S; Kitamura K; Kajimoto M
    Nihon Hinyokika Gakkai Zasshi; 2006 Sep; 97(6):791-5. PubMed ID: 17025212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The result of mass screening of 1997 for prostatic cancer in Isesaki City].
    Kobayashi M; Takezawa Y; Nakata S; Inoue M; Kurihara H; Kondo T; Kosaku N; Matsumoto K; Nakazato H; Yamanaka H
    Nihon Hinyokika Gakkai Zasshi; 2000 Jan; 91(1):1-7. PubMed ID: 10689876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of early detection for prostate cancer in mass screening].
    Kato M; Tammbo M; Yoshimatsu T; Ohta M; Kinjyo M; Noda H; Watanabe K; Miyata A; Murata A; Miura I; Yoneda T; Yoshii M; Okegawa T; Kojima M; Sayama T; Nutahara K; Higashihara E
    Nihon Hinyokika Gakkai Zasshi; 2001 Jan; 92(1):23-9. PubMed ID: 11235139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass screening of prostate cancer in Changchun City of China.
    Li X; Tsuji I; Kuwahara M; Zhang H; Wang H; Zhang L; Ji G; Zhao X
    Int Urol Nephrol; 2004; 36(4):541-8. PubMed ID: 15787333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mass screening for prostate cancer at Ikeda City in Osaka Prefecture--results of screening with PSA alone between 2003 and 2007].
    Inoue H; Kinouchi T; Kinoshita T; Kobayashi M; Ued T; Takada T; Hara T; Yamaguchi S; Kajimoto M; Kitamura K
    Nihon Hinyokika Gakkai Zasshi; 2010 Jul; 101(5):671-5. PubMed ID: 20715498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.
    Catalona WJ; Smith DS; Ratliff TL; Dodds KM; Coplen DE; Yuan JJ; Petros JA; Andriole GL
    N Engl J Med; 1991 Apr; 324(17):1156-61. PubMed ID: 1707140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical value of prostate specific antigen screening in early detection of prostate cancer].
    Hua LX; Qiao D; Song NH; Feng NH; Yang J; Zhang JX; Chen JG; Zhang W; Sui YG; Wu HF
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):705-9. PubMed ID: 20021870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening.
    Catalona WJ; Smith DS; Ratliff TL; Basler JW
    JAMA; 1993 Aug; 270(8):948-54. PubMed ID: 7688438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for prostate cancer using prostate-specific antigen testing in Japanese men on hemodialysis.
    Kurahashi T; Miyake H; Shinozaki M; Oka N; Takenaka A; Hara I; Matsumura Y; Fujisawa M
    Int Urol Nephrol; 2008; 40(2):345-9. PubMed ID: 17619159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements.
    Catalona WJ; Smith DS; Ornstein DK
    JAMA; 1997 May; 277(18):1452-5. PubMed ID: 9145717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
    Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
    JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer screening in Tyrol, Austria: experience and results.
    Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
    Eur Urol; 1999; 35(5-6):523-38. PubMed ID: 10325519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of men who present with elevated serum PSA (>20 ng/mL) to an inner-city hospital.
    Anai S; West CS; Chang M; Nakamura K; Pendleton J; Rosser CJ
    J Natl Med Assoc; 2007 Aug; 99(8):895-9. PubMed ID: 17722667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delays in cancer detection using 2 and 4-year screening intervals for prostate cancer screening with initial prostate specific antigen less than 2 ng/ml.
    Kundu SD; Grubb RL; Roehl KA; Antenor JA; Han M; Catalona WJ
    J Urol; 2005 Apr; 173(4):1116-20. PubMed ID: 15758718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for prostate cancer in Yahata, Kitakyushu].
    Fujimoto N; Harada S; Sato H; Akasaka S; Nomura M; Yamada Y; Ueno Y; Matsumoto T
    J UOEH; 2004 Jun; 26(2):239-44. PubMed ID: 15244076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of prostate specific antigen for early stage prostate cancer detection.
    Imai K; Ichinose Y; Kubota Y; Yamanaka H; Sato J; Saitoh M; Watanabe H; Ohe H
    Jpn J Clin Oncol; 1994 Jun; 24(3):160-5. PubMed ID: 7516445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project.
    Mettlin C; Murphy GP; Lee F; Littrup PJ; Chesley A; Babaian R; Badalament R; Kane RA; Mostofi FK
    Cancer; 1993 Sep; 72(5):1701-8. PubMed ID: 7688658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advantages and risks of the use of prostate-specific antigen (PSA) in the health-care area No. 4 of Gijon (Asturias)].
    Cepeda Piorno J; Rivas del Fresno M; Fuente Martín E; González García E; Muruamendiaraz Fernández V; Fernández Rodríguez E
    Arch Esp Urol; 2005 Jun; 58(5):403-11. PubMed ID: 16078781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for prostatic carcinoma with prostate specific antigen.
    Brawer MK; Chetner MP; Beatie J; Buchner DM; Vessella RL; Lange PH
    J Urol; 1992 Mar; 147(3 Pt 2):841-5. PubMed ID: 1371559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.